Novo Nordisk Lilly Shares Slump on Price-Cut Loom Plans
News of potential price reductions for popular GLP-1 therapies sparked a slide in Novo Nordisk and Eli Lilly shares. ...
Online resources offer a wealth of information for investment research. Learn how to leverage these tools to improve your investment approach.
21,367 articlesNews of potential price reductions for popular GLP-1 therapies sparked a slide in Novo Nordisk and Eli Lilly shares. ...
Bitcoin edges toward the long-term holder cost basis as on-chain data flags growing risk of capitulation. Analysts wa...
Ethereum climbs back toward $2,000 as volatility spikes, signaling a potential turning point for ETH. Traders weigh t...
A sweeping national poll reveals growing resistance to AI-powered ads that appear inside chat tools and digital assis...
The founder is back at Simply Good Foods, triggering a shift in market mood as insiders buy and Reddit chatter tilts ...
A volatile week looms for crypto as macro headlines, geopolitics, and policy signals converge. Here are the five thin...
OpenAI’s Sam Altman apologized for sloppy wording in announcing a Pentagon contract, pledging a revised release to em...
Goldman Sachs flags four tech, media, and telecom bets on its Conviction List, each carrying 40% to 100% upside to ta...
A proposed federal 401(k) match faces a reality gap: while it aims to help workers without employer plans, millions a...
Bitcoin regained some ground in a choppy session, but analysts say the bounce is more relief than a durable uptrend. ...
Bitcoin reclaims the $70,000 level as macro tensions and a large options stack around the strike drive hedging flows....
A late-February U.S. intelligence assessment concluded that neither limited air strikes nor a prolonged war would lik...